CAR T Cell therapy - first patient treated with FT596 "off the shelf" product - longer term Mantle Cell data promising.

Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.

Treatment of Mantle Cell Lymphoma: ASH 2019 Update: Imbruvica-Rituxan promising - Initial reports on CAR T cell therapy

Parsaclisib is highly selective PI3Kδ inhibitor precision medicine being developed in refractory B-cell lymphomas

Research demonstrates that some patients with NHL can be treated with 4 instead of 6 cycles of R-CHOP.

Ten things every patient with lymphoma should consider in order to get the best possible treatment

Heavy Cigarette Use and Alcohol Consumption May Reduce Survival in Patients with Non-Hodgkin’s Lymphoma

Overview of Autologous Stem Cell Transplant for treatment of Burkitts, small cleaved and highly aggressive NHL